Cysteamine

CAS No. 60-23-1

Cysteamine ( β-MEA;β-Mercaptoethylamine;Decarboxycysteine;MEA;Thioethanolamine )

Catalog No. M15246 CAS No. 60-23-1

An agent for the treatment of nephropathic cystinosis and an antioxidant.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
500MG 45 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Cysteamine
  • Note
    Research use only, not for human use.
  • Brief Description
    An agent for the treatment of nephropathic cystinosis and an antioxidant.
  • Description
    An agent for the treatment of nephropathic cystinosis and an antioxidant; increases intracellular glutathione levels in cystinotic cells, also increases the rates of apoptosis in cystinotic cells; is an excellent scavenger of OH and HOCl and also reacts with H2O2; significantly increase the intracellular GSH levels; also causes autophagosome accumulation in cancer cells.Other Indication Approved
  • Synonyms
    β-MEA;β-Mercaptoethylamine;Decarboxycysteine;MEA;Thioethanolamine
  • Pathway
    Autophagy
  • Target
    Autophagy
  • Recptor
    Cystine;NPYR2;SomatostatinReceptor
  • Research Area
    Other Indications
  • Indication
    Other Disease

Chemical Information

  • CAS Number
    60-23-1
  • Formula Weight
    77.15
  • Molecular Formula
    C2H7NS
  • Purity
    >98% (HPLC)
  • Solubility
    10 mM in DMSO
  • SMILES
    NCCS
  • Chemical Name
    Ethanethiol, 2-amino-

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Besouw, M, et al. Drug Discov Today, 2013. 18(15-16): p. 785-92.
2. de Matos, D.G, et al. Mol Reprod Dev, 1995. 42(4): p. 432-6.
3. Wan XM, et al. Int J Cancer. 2011 Sep 1;129(5):1087-95.
molnova catalog
related products
  • DMXAA

    A vascular disrupting agent (VDA) and competitive inhibitor of DT-diaphorase with Ki of 20 uM; activates STING dependent innate immune pathways.

  • ULK-101

    ULK-101 suppresses autophagy induction and autophagic flux in response to different stimuli.

  • Glycycoumarin

    Glycycoumarin is an estrogen agonist, it shows moderate inhibitory effects against CYP1A2 and CYP2B6.